易明医药：2025年第三季度归属于上市公司股东的净利润同比增长1934.12%

Core Insights - The company reported a revenue of 177,538,389.36 yuan for Q3 2025, representing a year-on-year growth of 10.37% [1] - The net profit attributable to shareholders reached 44,206,127.26 yuan, showing a significant year-on-year increase of 1934.12% [1] Financial Performance - Revenue for Q3 2025: 177.54 million yuan, up 10.37% year-on-year [1] - Net profit for Q3 2025: 44.21 million yuan, up 1934.12% year-on-year [1]